Collections

This file is in the following collections:

Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors Open Access (recommended)

Descriptions

Resource type(s)

Article

Keyword

cardiovascular disease
cardiovascular risk factors
coronavirus disease 2019
COVID-19
management
SARS-CoV-2
treatment

Rights

Attribution-NonCommercial 3.0 United States

Creator

Gupta, Ajay K.
Jneid, Hani
Addison, Daniel
Ardehali, Hossein
Boehme, Amelia K.
Borgaonkar, Sanket
Boulestreau, Romain
Clerkin, Kevin
Delarche, Nicolas
DeVon, Holli A.
Grumbach, Isabella M.
Gutierrez, Jose
Jones, Daniel A.
Kapil, Vikas
Maniero, Carmela
Mentias, Amgad
Miller, Pamela S.
Ng, Sher May
Parekh, Jai D.
Sanchez, Reynaldo H.
Sawicki, Konrad Teodor
te Riele, Anneline S. J. M.
Remme, Carol Ann
London, Barry

Abstract

Coronavirus Disease 2019 (COVID-19) has infected more than 3.0 million people worldwide and killed more than 200,000 as of April 27, 2020. In this White Paper, we address the cardiovascular co-morbidities of COVID-19 infection; the diagnosis and treatment of standard cardiovascular conditions during the pandemic; and the diagnosis and treatment of the cardiovascular consequences of COVID-19 infection. In addition, we will also address various issues related to the safety of healthcare workers and the ethical issues related to patient care in this pandemic.

Original Bibliographic Citation

Gupta AK, Jneid H, Addison D, Ardehali H, Boehme AK, Borgaonkar S, Boulestreau R, Clerkin K, Delarche N, DeVon HA, Grumbach IM, Gutierrez J, Jones DA, Kapil V, Maniero C, Mentias A, Miller PS, Ng SM, Parekh JD, Sanchez RH, Sawicki KT, te Riele A, Remme CA, London B. Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors. Journal of the American Heart Association. 2020;9(12):23.

Related URL

 https://www.ahajournals.org/doi/10.1161/JAHA.120.017013

Publisher

WILEY

Date Created

2020-06-16

Original Identifier

(PMID) 32347144

Language

English

Subject: MESH

COVID-19--complications
Cardiovascular Diseases

Subject: LCSH

COVID-19 (Disease)
Cardiovascular system--Diseases

Grants and funding

Dr Addison is supported by a National Cancer Institute K12CA133250 grant, Dr Grumbach by funding from the National Institutes of Health (R01 HL 108932), the Department of Veterans Affairs (I21 RX001561), and the American Heart Association (18IPA34170003).

DOI

10.1161/JAHA.120.017013

File Details

File Properties

Mime type: application/pdf

File size: 713.5 kB